Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

SPAST mutation spectrum and familial occurrence among Czech patients with pure hereditary spastic paraplegia

AU. Mészárosová, M. Putzová, M. Čermáková, D. Vávrová, K. Doležalová, I. Smetanová, D. Stejskal, C. Beetz, P. Seeman,

. 2016 ; 61 (10) : 845-850. [pub] 20160623

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17023587

Grantová podpora
NV15-33041A MZ0 CEP - Centrální evidence projektů

Digitální knihovna NLK
Plný text - Článek
Zdroj

E-zdroje Online Plný text

NLK Free Medical Journals od 1977
ProQuest Central od 2000-01-01 do Před 1 rokem
Health & Medicine (ProQuest) od 2000-01-01 do Před 1 rokem

The SPAST gene has a major role in hereditary spastic paraplegias (HSPs). This is the first report mapping characteristics of the SPAST gene in a large cohort of Czech HSP patients. All 17 coding exons of the SPAST gene were Sanger sequenced in 327 patients from 263 independent families with suspected uncomplicated HSP. The selected 126 independent patients, without mutation in the SPAST gene after Sanger sequencing, were subsequently tested by Multiplex Ligation-dependent Probe Amplification (MLPA) assay for large deletions or copy number variations affecting the SPAST gene. Among the 263 independent patients, 35 different, small mutations in 44 patients were found. Twenty-one mutations are novel with the majority of frameshift mutations. Seven mutations were found in more than one family. The age at onset ranged between preschool childhood and the fifth decade with inter- and intra-familiar differences. SPAST small mutations were detected in 16.7% (44/263) of independent tested patients. Mutations in the SPAST gene were found more frequently in familial cases (with affected relatives). Mutation were found in 31.9% (29/91 familial tested) in the familial patient group, whereas in the sporadic patient group, mutations were found in only 4.7% of cases (5/106 sporadic cases). Among SPAST-positive patients, 65.9% (29/44) were familial but only 11.4% (5/44) were sporadic. MLPA testing revealed four large deletions in four independent patients, all in familial-positive cases. Mutations in the SPAST gene are 5.8 × more frequent in familial than in sporadic cases. Large deletions were found only in familial patients. Diagnostic testing of the SPAST gene is useful only in positive family history patients not in sporadic cases.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17023587
003      
CZ-PrNML
005      
20201112094952.0
007      
ta
008      
170720s2016 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/jhg.2016.73 $2 doi
035    __
$a (PubMed)27334366
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Mészárosová, Anna Uhrová $u DNA Laboratory, Department of Child Neurology, Charles University Second Medical School and University Hospital Motol, Prague, Czech Republic.
245    10
$a SPAST mutation spectrum and familial occurrence among Czech patients with pure hereditary spastic paraplegia / $c AU. Mészárosová, M. Putzová, M. Čermáková, D. Vávrová, K. Doležalová, I. Smetanová, D. Stejskal, C. Beetz, P. Seeman,
520    9_
$a The SPAST gene has a major role in hereditary spastic paraplegias (HSPs). This is the first report mapping characteristics of the SPAST gene in a large cohort of Czech HSP patients. All 17 coding exons of the SPAST gene were Sanger sequenced in 327 patients from 263 independent families with suspected uncomplicated HSP. The selected 126 independent patients, without mutation in the SPAST gene after Sanger sequencing, were subsequently tested by Multiplex Ligation-dependent Probe Amplification (MLPA) assay for large deletions or copy number variations affecting the SPAST gene. Among the 263 independent patients, 35 different, small mutations in 44 patients were found. Twenty-one mutations are novel with the majority of frameshift mutations. Seven mutations were found in more than one family. The age at onset ranged between preschool childhood and the fifth decade with inter- and intra-familiar differences. SPAST small mutations were detected in 16.7% (44/263) of independent tested patients. Mutations in the SPAST gene were found more frequently in familial cases (with affected relatives). Mutation were found in 31.9% (29/91 familial tested) in the familial patient group, whereas in the sporadic patient group, mutations were found in only 4.7% of cases (5/106 sporadic cases). Among SPAST-positive patients, 65.9% (29/44) were familial but only 11.4% (5/44) were sporadic. MLPA testing revealed four large deletions in four independent patients, all in familial-positive cases. Mutations in the SPAST gene are 5.8 × more frequent in familial than in sporadic cases. Large deletions were found only in familial patients. Diagnostic testing of the SPAST gene is useful only in positive family history patients not in sporadic cases.
650    _2
$a adenosintrifosfatasy $x genetika $7 D000251
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a alely $7 D000483
650    _2
$a Česká republika $7 D018153
650    _2
$a mutační analýza DNA $7 D004252
650    _2
$a exony $7 D005091
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a genotyp $7 D005838
650    _2
$a lidé $7 D006801
650    _2
$a introny $7 D007438
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    12
$a mutace $7 D009154
650    _2
$a rodokmen $7 D010375
650    _2
$a fenotyp $7 D010641
650    _2
$a polymorfismus genetický $7 D011110
650    _2
$a sekvenční analýza DNA $7 D017422
650    _2
$a sekvenční delece $7 D017384
650    _2
$a spastická paraplegie dědičná $x diagnóza $x genetika $7 D015419
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
700    1_
$a Putzová, Martina $u Centre for Medical Genetics and Reproductive Medicine GENNET, Prague, Czech Republic.
700    1_
$a Čermáková, Marie $u Centre for Medical Genetics and Reproductive Medicine GENNET, Prague, Czech Republic.
700    1_
$a Vávrová, Dagmar $u Centre for Medical Genetics and Reproductive Medicine GENNET, Prague, Czech Republic.
700    1_
$a Doležalová, Kateřina $u Centre for Medical Genetics and Reproductive Medicine GENNET, Prague, Czech Republic.
700    1_
$a Smetanová, Irena $u Centre for Medical Genetics and Reproductive Medicine GENNET, Prague, Czech Republic.
700    1_
$a Stejskal, David $u Centre for Medical Genetics and Reproductive Medicine GENNET, Prague, Czech Republic.
700    1_
$a Beetz, Christian $u Department of Clinical Chemistry and Laboratory Medicine, Universitatsklinikum, Jena, Germany.
700    1_
$a Seeman, Pavel $u DNA Laboratory, Department of Child Neurology, Charles University Second Medical School and University Hospital Motol, Prague, Czech Republic. Centre for Medical Genetics and Reproductive Medicine GENNET, Prague, Czech Republic.
773    0_
$w MED00005297 $t Journal of human genetics $x 1435-232X $g Roč. 61, č. 10 (2016), s. 845-850
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27334366 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170720 $b ABA008
991    __
$a 20201112094949 $b ABA008
999    __
$a ok $b bmc $g 1239268 $s 984500
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 61 $c 10 $d 845-850 $e 20160623 $i 1435-232X $m Journal of human genetics $n J Hum Genet $x MED00005297
GRA    __
$a NV15-33041A $p MZ0
LZP    __
$a Pubmed-20170720

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...